Feasibility study of oral cyclophosphamide salvage therapy for the treatment of heavily pretreated patients with recurrent epithelial ovarian cancer

被引：0
|
作者：
Yoh Watanabe
Tomomaro Etoh
Eiji Koike
Yoshiaki Mizuno
Wei-Min Wang
Hiroshi Hoshiai
机构：
[1] Kinki University School of Medicine,Department of Obstetrics and Gynecology
来源：
International Journal of Clinical Oncology | 2010年 / 15卷
关键词：
Recurrent ovarian cancer; Salvage therapy; Cyclophosphamide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：468 / 471
页数：3
相关论文
共 50 条
  • [41] Combination of trastuzumab and gemcitabine as salvage therapy in heavily pretreated patients with metastatic breast cancer
    Bartsch, R.
    Wenzel, C.
    Pluschnig, U.
    Altorjai, G.
    Dubsky, P.
    Scheurer, R.
    Rottenfusser, A.
    Gnant, M.
    Zielinski, C. C.
    Steger, G. G.
    EJC SUPPLEMENTS, 2008, 6 (07): : 178 - 179
  • [42] Three-Day Topotecan Schedule in Heavily Pretreated Recurrent Ovarian Cancer Patients
    Calcagno, Marco
    Bellati, Filippo
    Palaia, Innocenza
    Plotti, Francesco
    Basile, Stefano
    Pastore, Maria
    Sansone, Milena
    Arrivi, Cristiana
    Angioli, Roberto
    Panici, Pierluigi Benedetti
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (03) : 455 - 459
  • [43] Intra-arterial hepatic chemotherapy in heavily pretreated patients with epithelial ovarian cancer
    Mambrini, A
    Caudana, R
    Zamagni, D
    Rabbi, C
    Del Freo, A
    Sanguinetti, F
    Fiorentini, G
    Cantore, M
    ANNALS OF ONCOLOGY, 2005, 16 (02) : 334 - 335
  • [44] The use of weekly topotecan in the treatment of heavily pretreated recurrent epithelial ovarian and primary peritoneal cancer: The Kaohsiung Chang Gung experience
    Hu, Ching-Fen
    Ou, Yu-Che
    Fu, Hung-Chun
    Chien, Chan-Chao Chang
    Tsai, Chin-Chou
    Wu, Chen-Hsuan
    Lin, Hao
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2015, 54 (01): : 43 - 47
  • [45] Maintenance Therapy in the Treatment of Recurrent Epithelial Ovarian Cancer
    Gnade, Colette
    Mcdonald, Megan E.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2020, 63 (01): : 86 - 91
  • [46] Retrospective analysis of topotecan administered weekly in heavily pretreated recurrent epithelial ovarian carcinoma patients.
    O'Malley, D
    Makkenchery, A
    Tangir, J
    Kelly, M
    Azodi, M
    Chambers, S
    Schwartz, P
    Rutherford, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 468S - 468S
  • [47] Feasibility of bevacizumab (BEV) plus chemotherapy in heavily pretreated ovarian cancer (OC) patients (pts): A retrospective study
    Asmane, I.
    Guastalla, J. P.
    Meeus, P.
    Moullet, I.
    Ardisson, P.
    Vincent, L.
    Coeffic, D.
    Dufresne, A.
    Bajard, A.
    Ray-Coquard, I. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Phase II study of single-agent gemcitabine in heavily pretreated Japanese patients with recurrent ovarian cancer
    Watanabe, Yoh
    Koike, Eiji
    Nakai, Hidekatsu
    Etoh, Tomomaro
    Hoshiai, Hiroshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (04) : 345 - 348
  • [49] Phase II study of single-agent gemcitabine in heavily pretreated Japanese patients with recurrent ovarian cancer
    Yoh Watanabe
    Eiji Koike
    Hidekatsu Nakai
    Tomomaro Etoh
    Hiroshi Hoshiai
    International Journal of Clinical Oncology, 2008, 13 : 345 - 348
  • [50] Bevacizumab combination therapy in heavily pretreated, recurrent cervical cancer
    Wright, Jason D.
    Viviano, Dana
    Powell, Matthew A.
    Gibb, Randall K.
    Mutch, David G.
    Grigsby, Perrv W.
    Rader, Janet S.
    GYNECOLOGIC ONCOLOGY, 2006, 103 (02) : 489 - 493
12345